Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 11
2003 13
2004 21
2005 20
2006 11
2007 10
2008 12
2009 15
2010 7
2011 14
2012 7
2013 4
2014 5
2015 4
2016 1
2017 5
2018 2
2019 8
2020 9
2021 7
2022 1
2023 4
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Results by year

Filters applied: . Clear all
Page 1
[CA72-4 (TAG-72)].
Maida Y, Kyo S, Inoue M. Maida Y, et al. Among authors: inoue m. Nihon Rinsho. 2005 Aug;63 Suppl 8:672-4. Nihon Rinsho. 2005. PMID: 16149608 Review. Japanese. No abstract available.
[Translational research].
Inoue M. Inoue M. Nihon Rinsho. 2012 Jun;70 Suppl 4:67-70. Nihon Rinsho. 2012. PMID: 23156219 Free article. Japanese. No abstract available.
Aromatase and leiomyoma of the uterus.
Shozu M, Murakami K, Inoue M. Shozu M, et al. Among authors: inoue m. Semin Reprod Med. 2004 Feb;22(1):51-60. doi: 10.1055/s-2004-823027. Semin Reprod Med. 2004. PMID: 15083381 Review.
Prolyl isomerase Pin1 in metabolic reprogramming of cancer cells.
Nakatsu Y, Yamamotoya T, Ueda K, Ono H, Inoue MK, Matsunaga Y, Kushiyama A, Sakoda H, Fujishiro M, Matsubara A, Asano T. Nakatsu Y, et al. Cancer Lett. 2020 Feb 1;470:106-114. doi: 10.1016/j.canlet.2019.10.043. Epub 2019 Oct 31. Cancer Lett. 2020. PMID: 31678165 Review.
Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
Okubo H, Nakatsu Y, Kushiyama A, Yamamotoya T, Matsunaga Y, Inoue MK, Fujishiro M, Sakoda H, Ohno H, Yoneda M, Ono H, Asano T. Okubo H, et al. Curr Med Chem. 2018;25(9):984-1001. doi: 10.2174/0929867324666171009121702. Curr Med Chem. 2018. PMID: 28990516 Review.
Development of Pin1 Inhibitors and their Potential as Therapeutic Agents.
Nakatsu Y, Matsunaga Y, Ueda K, Yamamotoya T, Inoue Y, Inoue MK, Mizuno Y, Kushiyama A, Ono H, Fujishiro M, Ito H, Okabe T, Asano T. Nakatsu Y, et al. Curr Med Chem. 2020;27(20):3314-3329. doi: 10.2174/0929867325666181105120911. Curr Med Chem. 2020. PMID: 30394205 Review.
How to inhibit telomerase activity for cancer therapy.
Kyo S, Inoue M. Kyo S, et al. Among authors: inoue m. Curr Med Chem Anticancer Agents. 2002 Sep;2(5):613-26. doi: 10.2174/1568011023353796. Curr Med Chem Anticancer Agents. 2002. PMID: 12678728 Review.
187 results